Divi's Laboratories has reported results for third quarter ended December 31, 2022. (Q3FY23)
The company has reported fall of 65.73% in its net profit at Rs 310.90 crore for Q3FY23 as compared to Rs 907.22 crore for the corresponding quarter previous year. Total income of the company decreased by 27.27% to Rs 1806.17 crore for the quarter under review as compared to Rs 2483.39 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported fall of 66% in its net profit at Rs 306.80 crore for Q3FY23 as compared to Rs 902.24 crore for the same quarter in the previous year. Total income of the company decreased by 27.41% to Rs 1821.93 crore for the quarter under review as compared to Rs 2509.86 crore for the same quarter in the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1521.95 |
Dr. Reddys Lab | 6279.95 |
Cipla | 1407.55 |
Zydus Lifesciences | 963.50 |
Lupin | 1640.30 |
View more.. |